Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2018
/
Article
/
Tab 7
/
Research Article
IgG Antibodies to GlcNAc
β
and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
Table 7
Correlation between the AG Ab level and clinical parameters of patients.
Abs
Parameter
Adi in F0
Viral load
25
0.47
0.017
Adi in F0–1
Viral load
35
0.44
0.008
Adi in F0–4
Viral load
62
0.37
0.012
Adi in F0–4
Anti-HCV Abs
35
−0.61
0.001
Adi
Monocytes (count/mL)
54
−0.32
0.017
GA2 in F0–4
Anti-HCV Abs
38
0.39
0.017
GA2 in F0–4
AFP
29
0.63
<0.001
Gb5tri in F0–4
ALP
67
0.37
0.002
Gb5tri in F1–4
ALP
43
0.46
0.002
TF
β
in F1–4
ALP
43
0.38
0.025
Viral load
Anti-HCV Abs
38
−0.40
0.042
Tn
Lymphocytes (count/mL)
35
−0.52
0.002
GalNAc
β
Bilirubin
53
0.31
0.024
denotes Spearman’s correlation coefficient.